Overview Financials News + Filings Key Docs Charts Ownership Insiders |
Adaptive Biotechnologies Corp (ADPT)
|
Add to portfolio |
|
|
Price: |
$28.90
| | Metrics |
OS: |
144.6
|
M
| |
|
|
Market cap: |
$4.18
|
B
| |
|
|
Net cash:
|
$417
|
M
| |
$2.88
|
per share
|
EV:
|
$3.76
|
B
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
($230)
|
M
| |
|
|
EBIT
|
|
| |
|
|
EPS |
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
Revenues | 154.3 | 98.4 | 85.1 | 55.7 | 38.4 |
Revenue growth | 56.9% | 15.6% | 52.8% | 44.8% | |
Cost of goods sold | 49.3 | 22.5 | 22.3 | 19.7 | 15.7 |
Gross profit | 105.0 | 75.9 | 62.8 | 36.0 | 22.8 |
Gross margin | 68.1% | 77.1% | 73.8% | 64.7% | 59.2% |
Sales and marketing | 95.5 | 61.4 | 38.5 | 24.5 | 16.8 |
Research and development | 142.3 | 116.1 | 70.7 | 39.2 | 32.0 |
General and administrative | 74.5 | 49.5 | 30.3 | 20.4 | 15.9 |
EBITA | -207.3 | -151.1 | -76.7 | -48.1 | -41.9 |
EBITA margin | -134.3% | -153.6% | -90.2% | -86.3% | -109.1% |
Amortization of intangibles | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 |
EBIT | -209.0 | -152.8 | -78.4 | -49.8 | -43.6 |
EBIT margin | -135.4% | -155.3% | -92.1% | -89.4% | -113.5% |
Pre-tax income | -207.3 | -146.2 | -68.6 | -46.4 | -42.8 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | -207.3 | -146.2 | -69.6 | -46.3 | -42.7 |
Net margin | -134.3% | -148.6% | -81.8% | -83.3% | -111.0% |
|
Diluted EPS | ($1.48) | ($1.11) | ($1.01) | ($3.67) | ($3.50) |
Shares outstanding (diluted) | 140.4 | 131.2 | 69.2 | 12.6 | 12.2 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|